The anti-hypertensive drugs market has experienced steady growth in recent years, expanding from $35.8 billion in 2023 to $36.7 billion in 2024, representing a compound annual growth rate (CAGR) of 2.5%. This growth in the historic period is attributed to various factors such as environmental and lifestyle influences, historical market competition, treatment preferences over time, economic conditions, and global health trends prevalent in the past. Looking ahead to 2028, the market size is expected to continue its upward trajectory, reaching $40.28 billion at a CAGR of 2.4%. Factors influencing this forecast include cost-effectiveness, emerging therapeutic innovations, epidemiological trends, regulatory changes and approvals, the dynamics of an aging population, and shifts in healthcare policies.
Major Driver In The Anti Hypertensive Drugs Market
A sedentary lifestyle serves as a primary catalyst for the expansion of the anti-hypertensive drug market. Factors such as the consumption of junk food, inadequate intake of a healthy and balanced diet, and disrupted sleep patterns due to irregular work shifts have contributed to the prevalence of hypertension. Hypertension, in turn, accounts for a significant portion of heart disease and stroke-related fatalities, constituting 45% and 51% of deaths, respectively. Upon diagnosis, patients typically require drugs to manage hypertension based on its severity. Moreover, data from June 2021 by the World Health Organization underscores the pervasive threat of cardiovascular diseases (CVDs), claiming an estimated 17.9 million lives annually worldwide. This sustains a consistent demand for anti-hypertensive drugs, serving as a key driver for market growth. In 2023, the anti-hypertensive drug market stood at $X billion and is projected to reach $Y billion by 2024, further climbing to $Z billion by 2028.
Request A Free Sample Of The Global Anti Hypertensive Drugs Market Report
Anti Hypertensive Drugs Market Competitive Landscape
Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy's Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, United Therapeutics, Torrent Pharmaceuticals Ltd, Ranbaxy Laboratories, Noden Pharma DAC, Acacia Pharma Group Plc, Actelion Pharmaceuticals Ltd.
Key Anti Hypertensive Drugs Market Trend
Major companies operating in the anti-hypertensive drugs market are focusing on innovating new products, such as Metoprolol Succinate Extended-Release Tablets, to provide a competitive edge in the market. Metoprolol Succinate Extended-Release Tablets are used as anti-hypertensive drugs for patients with hypertension. For instance, in June 2023, Granules India Limited, an Indian-based pharmaceutical manufacturing company, launched Metoprolol Succinate Extended-Release Tablets approved by the Food and Drug Administration (FDA), a US-based federal agency. Metoprolol Succinate Extended-Release Tablets are anti-hypertensive drugs designed for the treatment of hypertension in order to lower blood pressure. These tablets are available in varying strengths, including 25mg, 50mg, 100mg, and 200mg. This consists of beta-blockers that slow down the heart rate, reduce the workload on the heart, and lower blood pressure.
Get The Full Global Anti Hypertensive Drugs Market Report
Anti Hypertensive Drugs Market Segmentation
The anti-hypertensive drugs market covered in this report is segmented –
1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators
2) By Disease Source: Primary Hypertension, Secondary Hypertension
3) By End Users: Hospitals, Clinics, Homecare
By Geography:The regions covered in the anti-hypertensive drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the anti-hypertensive drugs market in 2023.
The Anti Hypertensive Drugs Global Market Report 2024 furnishes information about the global anti hypertensive drugs market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.
